According to a new report by UnivDatos, the Pulmonary Arterial Hypertension Market is expected to reach USD 11.5 Billion in 2032 by growing at a CAGR of ~5%. Key Highlights of the Report: Ø Growing cases of PAH: The growing prevalence of PAH is driving the higher demand for PAH-targeting therapeutics in the market. Ø Rising adoption of personalized medicine in the...